Promising Growth Stocks To Watch Now - August 5th

Key Points

• Circle Internet Group is focused on creating a new global economic system and has seen significant trading activity, with its stock reaching a recent low of $159.79.
• Novo Nordisk A/S has a strong market cap of $210.60 billion and operates in the pharmaceutical sector, particularly focusing on Diabetes and Obesity Care.
• Apollo Global Management specializes in private equity investments and has a market cap of $83.55 billion, with a notable recent trading performance hitting $146.19 per share.

Circle Internet Group, Novo Nordisk A/S, and Apollo Global Management are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to grow revenues or earnings at above-average rates compared to the overall market. Such firms typically reinvest profits into expansion, research or acquisitions rather than paying dividends, resulting in higher valuation multiples and the potential for significant capital appreciation—albeit with greater volatility and risk. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Circle Internet Group (CRCL)

Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

Circle Internet Group stock traded down $5.03 during midday trading on Tuesday, hitting $159.79. 4,385,088 shares of the stock were exchanged, compared to its average volume of 29,849,492. Circle Internet Group has a fifty-two week low of $64.00 and a fifty-two week high of $298.99. The stock has a market cap of $35.56 billion and a P/E ratio of -12,627.63.

Read Our Latest Research Report on CRCL

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NVO stock traded down $1.64 during trading on Tuesday, reaching $47.17. The company's stock had a trading volume of 12,359,836 shares, compared to its average volume of 10,806,354. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.74 and a quick ratio of 0.56. The company has a market capitalization of $210.60 billion, a price-to-earnings ratio of 13.97, a P/E/G ratio of 1.46 and a beta of 0.63. The stock's 50-day moving average price is $68.89 and its 200 day moving average price is $72.37. Novo Nordisk A/S has a 1-year low of $46.90 and a 1-year high of $139.74.

Read Our Latest Research Report on NVO

Apollo Global Management (APO)

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.

Apollo Global Management stock traded up $4.17 during trading hours on Tuesday, reaching $146.19. 3,342,404 shares of the stock were exchanged, compared to its average volume of 3,615,816. The stock has a market cap of $83.55 billion, a P/E ratio of 25.64, a P/E/G ratio of 1.56 and a beta of 1.62. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.36 and a current ratio of 1.36. Apollo Global Management has a 52-week low of $101.45 and a 52-week high of $189.49. The firm's 50 day moving average is $140.86 and its 200 day moving average is $141.90.

Read Our Latest Research Report on APO

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.